View in EDS HTML Full Text PDF Full Text

Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
Authors: Xu ZJ; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Jin Y; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China., Zhang XL; Department of Hematology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, People's Republic of China., Xia PH; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Wen XM; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Ma JC; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Lin J; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China., Qian J; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; Department of Hematology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, People's Republic of China.
Source: Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 789-807. Date of Electronic Publication: 2022 May 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35642341
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xu+ZJ%22">Xu ZJ</searchLink>; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Jin+Y%22">Jin Y</searchLink>; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Zhang+XL%22">Zhang XL</searchLink>; Department of Hematology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Xia+PH%22">Xia PH</searchLink>; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Wen+XM%22">Wen XM</searchLink>; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Ma+JC%22">Ma JC</searchLink>; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Qian+J%22">Qian J</searchLink>; Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.; Department of Hematology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, People's Republic of China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101595310%22">Cancer medicine</searchLink> [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 789-807. <i>Date of Electronic Publication: </i>2022 May 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd%22">John Wiley & Sons Ltd </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101595310 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-7634 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220457634%22">20457634 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35642341
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.4905
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 789
    Titles:
      – TitleFull: Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu ZJ
      – PersonEntity:
          Name:
            NameFull: Jin Y
      – PersonEntity:
          Name:
            NameFull: Zhang XL
      – PersonEntity:
          Name:
            NameFull: Xia PH
      – PersonEntity:
          Name:
            NameFull: Wen XM
      – PersonEntity:
          Name:
            NameFull: Ma JC
      – PersonEntity:
          Name:
            NameFull: Lin J
      – PersonEntity:
          Name:
            NameFull: Qian J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023 Jan
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2045-7634
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer medicine
              Type: main
ResultId 1